HDV-Insulin Lispro (HDV-LIS) met A1C non-inferiority at Weeks 12 and 25, confirming comparable glycemic control to insulin lispro (LIS) with point-estimate differences below FDA-required 0.1% ...
Zealand Pharma announces Boehringer Ingelheim's survodutide Phase III trial showed targeted 34% visceral and 63% liver fat ...
Morning Overview on MSN
Light from the nearest star beyond the sun takes more than four years to reach us
Every photon that leaves Proxima Centauri, the nearest star beyond the Sun, crosses more than four light-years of empty space ...
Researchers shared findings today at the American Diabetes Association Scientific Sessions (ADA 2026) in New Orleans. San ...
A new meta-analysis found no statistically significant difference in positive affect, negative affect, or life satisfaction ...
Edgewise Therapeutics (EWTX) stays a Buy after its $2.65B Servier deal funds EDG-7500 for HCM with key Q2 2026 data. Read ...
Austin, Texas - Eric M. Willie, a family law attorney in Austin, has compiled a new analysis of marriage and divorce ...
The AUA 2026 conference featured practice-changing abstracts in the field of urologic oncology. Urologists from Fox Chase ...
International guidelines on the use of routinely collected data set new quality standards—The increasing availability of ...
The INDIGO study met its primary and all key secondary endpoints with statistically significant results - - Obexelimab significantly lowered the total amount of glucocorticoid use and reduced ...
Thank you, Morgan, and thank you all for joining us for our fiscal year 2025 earnings call. With me this morning are Dr. Julie Krop, our Chief Medical Officer; and Scott Kellen, our Chief Financial ...
Extensive research reveals the CDC's weekly publication drew unsupported conclusions about mask effectiveness based on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results